15 million vaccines were scrapped due to mistakes! U.S. plant will focus on the production of Johnson & Johnson vaccines

　　China News Service, April 4th. Comprehensive foreign media reported that employees at a new crown vaccine manufacturing plant in the United States mistakenly mixed two new crown vaccine raw materials, resulting in 15 million doses of Johnson & Johnson's new crown vaccine forced to be destroyed, local time on the 3rd. , The US government has ordered the plant to stop producing another vaccine, and only focus on the production of Johnson & Johnson vaccine.

On March 10, local time, Texas completely lifted the "mask order" and allowed companies to open at 100% capacity. This also means that companies in Texas can basically operate as usual before the outbreak.

The picture shows a lady working in a coffee shop.

　　According to reports, this vaccine manufacturing plant is located in Baltimore, Maryland, USA. It is operated by an American emerging biotechnology company. It also produces Johnson & Johnson vaccines and vaccines jointly developed by AstraZeneca Pharmaceuticals and the University of Oxford.

A few weeks ago, employees of the factory mistakenly conflated the raw materials of the two vaccines. As many as 15 million doses of Johnson & Johnson vaccine were scrapped.

　　On the 3rd local time, a US government official stated that the federal government has instructed Johnson & Johnson to completely take over the vaccine production of the plant, and Johnson & Johnson will exercise stricter control over its production process.

　　Johnson & Johnson also issued a statement stating that it will "take all the responsibilities of the vaccine manufacturing plant for vaccine manufacturing."

　　At the same time, the U.S. Department of Health and Human Services stated that the AstraZeneca vaccine will be produced in another factory, although it did not specify the specific circumstances.

AstraZeneca said it will work with the federal government to find alternative factories.

　　The New York Times quoted two federal health officials as reporting that the move by the US Department of Health and Human Services means that the factory will only manufacture a single dose of Johnson & Johnson vaccine in the future to avoid confusion.

　　The report pointed out that 24 million doses of Johnson & Johnson vaccines originally planned to be distributed across the United States by the end of April are produced by this factory, and the delivery of this batch of vaccines will be affected.

Currently, the United States has approved the use of three vaccines, from Pfizer, Modena and Johnson & Johnson.